Digital Partner for Biopharma · Biotech / CDMO / CRO

Where science meets its digital future.

BALAN BRIDGE partners with Biotech, CDMO and CRO organizations to design and deliver the digital enterprise — from strategy and blueprint to roadmap and implementation. One bridge, from molecule to market.

0+
Digital programs delivered
0+
Years of biopharma expertise
0%
Avg. faster time-to-decision
0×
Portfolio visibility, end-to-end
Built for the full biopharma value chain
BIOTECH · Discovery → BLA CDMO · Process → GMP Ops CRO · Preclinical → Clinical
About Us

A bridge between bench and byte.

BALAN BRIDGE is a digital firm dedicated to the biopharmaceutical industry. We believe the next generation of therapies will be built as much on data, platforms and digital operations as on science itself.

Our team combines deep domain knowledge across Biotech, CDMO and CRO operating models with hands-on digital delivery experience — so strategy never stays on slides, and technology never loses sight of science.

From the first strategy workshop to the last go-live, we stay accountable for outcomes: faster programs, clearer decisions, compliant operations.

Industry-native

We speak IND, GMP, and tech transfer — not just tech. Every engagement starts from how biopharma actually works.

Strategy to steel

One team carries the work from vision to implementation, so nothing is lost in translation between consultants and builders.

Compliance by design

GxP, data integrity and validation thinking are built into every blueprint from day one — not retrofitted at the end.

Services

Four moves. One continuous bridge.

A single, connected journey that takes your organization from ambition to operating reality — each stage building directly on the last.

01 / STRATEGY

Digital Strategy

Define where digital creates scientific and commercial value for your pipeline, plant, or platform.

  • Digital maturity assessment
  • Value-case & ambition setting
  • Operating-model alignment
02 / BLUEPRINT

Digital Blueprint

Translate strategy into a concrete enterprise architecture across data, applications, and processes.

  • Capability & process mapping
  • Data & application architecture
  • GxP / compliance framework
03 / ROADMAP

Digital Roadmap

Sequence initiatives into a funded, de-risked, milestone-driven plan the whole organization can commit to.

  • Initiative prioritization
  • Budget & resource planning
  • Quick wins & phasing
04 / IMPLEMENT

Digital Implementation

Deliver the systems, integrations, and adoption programs — and stay until value is measured, not promised.

  • Solution delivery & integration
  • Validation & data migration
  • Change & adoption enablement
Industries

Fluent in every operating model.

Biotech

Clinical-stage Biotech

Pipeline-first digital foundations: program & portfolio management, R&D data backbone, regulatory readiness — built lean for teams that must move fast on limited runway.

CDMO

Development & Manufacturing

Digital plant and client-facing transparency: MES/LIMS landscapes, tech-transfer digitization, capacity & scheduling intelligence, and GMP-grade data integrity.

CRO

Research Services

Throughput and trust at scale: study operations digitization, sponsor collaboration portals, quality systems, and analytics that turn service delivery into a differentiator.

Our Product · BRIDGE PPM

Your entire pipeline. One command center.

BRIDGE PPM is our pipeline & project management platform purpose-built for Biotech. Budgets, progress, tasks and resources — connected across every program, from candidate selection to filing.

Budgets

Plan, track and forecast spend per program and phase — with burn-rate alerts before overruns happen.

Progress

Live milestone and stage-gate tracking across the portfolio — from IND-enabling studies to BLA.

Tasks

Cross-functional task orchestration with dependencies, owners and CMC/clinical/regulatory views.

Resources

Capacity planning across FTEs, labs and external partners — see conflicts before they slow the science.

Portfolio Overview
6 active programs · FY2026
Q3 2026 ▾
Active programs
6
▲ 1 this quarter
Budget utilized
68%
on plan
Milestones on track
21/24
▲ 3 at risk
Open tasks
148
▼ 12% vs last month
Pipeline progress by programstage completion
BB-101 ADC · PH II
72% ON
BB-207 mAb · PH I
45% ON
BB-315 Bispecific · IND
88% ON
BB-422 CGT · PRECLIN
31% RISK
BB-508 ADC · PH I
56% ON
Budget vs. actual (USD M)
CMC
8.9/12
Clinical
11.6/19
Regulatory
2.3/2.5
Discovery
3.4/7
Resource load by function
CMC
CLIN
REG
QA
BD
BRIDGE PPM · Product interface preview
What Clients Say

Trusted where it matters most.

They turned our digital ambitions into a blueprint our board could fund and our scientists could believe in. Six months later, it was running.

CB
Chief Business OfficerClinical-stage Biotech

BRIDGE PPM gave us one truth across budgets, milestones and people. Portfolio reviews went from two days of slides to a live working session.

VP
VP, Program ManagementOncology Biotech

Rare partner that understands both GMP operations and modern platforms. Our tech transfer cycle time dropped measurably within two quarters.

SD
Site Digital LeadGlobal CDMO
Let's Talk

Ready to build your digital bridge?

Tell us about your pipeline, your plant, or your platform — we'll bring a point of view within one week.

Request a BRIDGE PPM Demo